Inpharma has been operating in the Russian market since 2009, and is offering a full range of services in the following areas:
Inpharma has successfully undergone audit in pharmacovigilance organized by an American-Irish business partner under a long-term services agreement and a QPPV. We have also prepared dozens of SOPs (Standard Operative Procedures), PSURs (Periodic Safety Update Reports), RMPs (Risk Management Plans) which are already in use by our customers.
The authorization activities for substances and finished dosage forms, performed by the company for our foreign colleagues, have been consistently followed by favorable decisions of the Ministry of Health of the Russian Federation. Once having authorized a product, Inpharma LLC provides the authorization support throughout its validity period in Russia, including authorization of prices and Marketing Authorization withdrawal. Our specialist English translators with vast experience in pharmaceutical translation actively facilitate acceleration of the authorization activities. Their medical translations are highly appreciated by our customers.
Customers of Inpharma LLC welcome the ability of communication with Russian manufacturers/suppliers/distributors on their behalf. Services for audit of authorization activities are available on request.
Preauthorization preparation, which, among other, includes market and competitor analysis for identification of the products subject to authorization, enables our clients to get a better picture of nomenclature to enter the Russian market, estimate all possible risks and benefits.
So, when working with Inpharma LLC you can count on quality and timely provision of services for authorization, pharmacovigilance and other business segments of Russian and foreign pharmaceutical companies.
Do you have questions?
Our specialists can answer your questions. You can call us or fill the form and our manager will connect to you.